ClinicalTrials.gg
RecruitingNCT06543680Updated Aug 9, 2024

Resin Modified Glass Ionomer Versus Self-Adhesive Resin Composite Restorative Systems

An interventional study of Dental restoration in Secondary Caries Dental Restoration Failure of Marginal Integrity, sponsored by Mansoura University. Recruiting at 1 site in Egypt. Open to participants aged 30 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-09.

Sponsored by Mansoura University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by May 2025, 1 year 5 months ago, but the record still lists the study as recruiting.
  • Registered 1 year 2 months after the study started (first participant enrolled May 2023, registered Aug 2024).
  • Started May 2023; still recruiting 3 years 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Randomized
Ages
30 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 19 studies in Dental Caries by Mansoura University — 5 open to participants now, 12 under way, none of them phase 3. Dental Caries · Mansoura University.

Planned enrollment
14th of 19
35 · median 40
Started
2023
with 1 other
No phase
19 of 19
5 open now
Primary completion
2025-05
later than 1 of 11 live
Registered
8th of 19
by date

Among the 19 studies in Dental Caries by Mansoura University, this one is the 14th largest by planned enrollment, is one of 2 that started in 2023, is one of 19 with no phase, reaches primary completion later than 1 of the 11 other live ones, and was the 8th registered.

Dental Caries

1,176 studies on the registry are indexed under Dental Caries; 209 are open to participants now.

Browse Dental Caries studies →

Open to participants now

5 of the 19 studies in Dental Caries by Mansoura University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 86 Dental Caries studies recruiting now, 18 (21%) set no upper age limit and 66 (77%) stop at 75 or younger; 60 take children under 18; 53 take healthy volunteers.

This study: 30 Years to 60 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 19 studies in Dental Caries by Mansoura University, or all of them as a file.
02

Study summary

To evaluate and compare two-year clinical performance of commercially available resin modified glass ionomer cement, self-adhesive composite hybrid and self-adhesive flowable composite restorative materials for non-carious cervical lesions

Read the detailed description

The experimental design description adhered to the guidelines provided by the Consolidated Standards of Reporting Trials (CONSORT) statement. The present study is planned as a double-blinded randomized clinical trial, ensuring that both the patients and the examiner are unaware of the treatment allocation. The trial will follow a parallel design. A total of 35 patients, who are seeking dental treatment, will be enrolled in the study. The participants will be recruited from the Operative Department clinic at the Faculty of Dentistry, University of Mansoura. The study will focus on 105 Class V restorations.A randomized clinical trial will be performed. A number of 35 patients will be included in this study. Each patient will have at least three NCCLs. One of these lesions will be randomly restored with resin modified glass ionomer cement, the second lesion will be restored with self-adhesive Surefil One composite hybrid while the third lesion will be restored with self-adhesive flowable composite.

No active advertisement will be used for participant recruitment, and instead, a convenience sample will be formed. Prior to participating in the study, each patient will be required to provide informed consent by signing a consent form. The study is scheduled to be conducted from may 2023 to may 2025. The form and protocol of the study will be approved by Mansoura University's ethics committee before initiation.

Clinical evaluation for all restorations will be done at baseline (after insertion) and after 6, 12 and 24 months of clinical service by two calibrated independent examiners that will not share in restorations placement. It will be designed depending on modified USPHS criteria and FDI criteria

03

Conditions studied

  • Secondary Caries Dental Restoration Failure of Marginal Integrity

Browse trials for

04

Who can participate

Ages eligible
30 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Inclusion criteria will be fair oral hygiene patients with 30-60 years. Patients with at least three similarly sized non-carious cervical lesions (NCCLs) in vital teeth that need for restoration and depth of NCCLs will be 1-3 mm with at least 50% of margins without enamel.

Exclusion criteria

Exclusion Criteria:

  • Exclusion criteria will be patients with severe periodontitis, mobile teeth, fractures, severe bruxism, carious teeth, poor oral hygiene, teeth with irreversible pulpitis and endodontically treated teeth.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
35 participants (estimated)

Study arms

  • Active comparator
    Resin Modified Glass Ionomer cement

    Each patient will randomly receive one cervical restoration with one of the tested restorative systems

    Other: Dental restoration

  • Placebo comparator
    Self-Adhesive flowable composite

    Each patient will randomly receive one cervical restoration with one of the tested restorative systems

    Other: Dental restoration

  • Placebo comparator
    Self-Adhesive composite hybrid

    Each patient will randomly receive one cervical restoration with one of the tested restorative systems

    Other: Dental restoration

Interventions

  • OtherDental restoration

    Each patient will randomly receive one cervical restoration with one of the tested restorative systems

06

What researchers measure

Primary outcomes

  1. Percentage of aesthetic, functional and biological properties for each group

    Percentage of aesthetic, functional and biological properties that will be clinically assessed using World Dental Federation and USPHS parameters for each restorative system group

    Time frame: 2 years after restoration

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Data will be available within 6 Months for 2 years

Access criteria: For any one

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2023 (actual). Primary completion is estimated for May 2025, 24 months after the start.

Of 470 non-industry interventional studies with no phase under Dental Caries, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's planned 24 months is above that.

Counting every sponsor, half of 503 studies reached it within 15 months; a quarter within 7 and three quarters within 29.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 4, 2024
First posted
Aug 9, 2024
StartActual
May 29, 2023
Primary completionEst.
May 29, 2025
CompletionEst.
May 31, 2025
Last update
Aug 9, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 9, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06543680
Responsible party
Mohamed Elbahloul (Assistant Lecturer, Mansoura University) — Principal investigator
First posted
Aug 9, 2024
Start date
May 29, 2023
Primary completion
May 29, 2025 (estimated)
Completion
May 31, 2025 (estimated)
Last update
Aug 9, 2024

Study contacts

Mohamed E Hamouda, Assistant Lecturer
Contact
mohamedelbahloul@mans.edu.eg
01018357630
Abeer E Elembaby, Professor
Contact
ab_elembaby@yahoo.com
01000033812
Mohamed E Hamouda, Assistant Lecturer
principal investigator · Faculty of Dentistry, Mansoura University, Egypt

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion